Cargando…
Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
Metastatic and drug-resistant melanoma are leading causes of skin cancer–associated death. Mitogen-associated protein kinase (MAPK) pathway inhibitors and immunotherapies have provided substantial benefits to patients with melanoma. However, long-term therapeutic efficacy has been limited due to eme...
Autores principales: | Reddi, Kiran Kumar, Guruvaiah, Praveen, Edwards, Yvonne J. K., Gupta, Romi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247198/ https://www.ncbi.nlm.nih.gov/pubmed/35785205 http://dx.doi.org/10.3389/fonc.2022.937831 |
Ejemplares similares
-
Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023) -
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022) -
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015) -
UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress
por: Dutta, Roshan, et al.
Publicado: (2022) -
Proteomics and
Phosphoproteomics Profiling of Drug-Addicted
BRAFi-Resistant Melanoma Cells
por: Li, Bohui, et al.
Publicado: (2021)